Median Technologies

Median Technologies develops AI-powered Software as a Medical Device (SaMD) for early cancer diagnostics. Their offerings include medical image analysis and management in oncology trials through iCRO, and the AI/ML-based suite, eyonis™. The company empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies.

Funding Round: Debt

Funding Amount: €4M

Date: 05-Feb-2025

Investors: Iris Capital

Markets: AI, Healthtech

HQ: Sophia Antipolis, France

Founded: 2002

Website: http://www.mediantechnologies.com

LinkedIn: https://www.linkedin.com/company/median-technologies

Twitter: https://twitter.com/MEDIANTechno

Instagram:

Facebook: https://www.facebook.com/MEDIAN-Technologies-2042849199275635/